Israel weighed “compassionate use” of Pluristem therapy for COVID-19
On Mar. 17, 2020, Israel’s Health Ministry announced that it had approved a request by Pluristem Therapeutics to…
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
Aimmune announced first U.S. patients treated with PALFORZIA, the first treatment for peanut allergy
On Mar. 16, 2020, Aimmune Therapeutics announced that the first patients in the U.S. were being treated with…
Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
CureVac focuses on development of mRNA-based coronavirus vaccine to protect people worldwide
On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus…
Fosun Pharma and BioNTech formed COVID-19 vaccine strategic alliance in China
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
CureVac’s optimized mRNA platform provided positive pre-clinical results at low dose for Coronavirus vaccine candidate
On Mar. 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
Disease | Therapeutics | WHO
National Emergency declared in U.S. for novel Coronavirus disease outbreak
On Mar. 13, 2020, the Federal Government, along with State and local governments, announced preventive and proactive measures…
Large scale COVID-19 testing of general population begun in Iceland
On Mar. 13, 2020, Iceland health authorities and deCode Genetics announced they began comprehensive screening for the virus…
Enanta Pharmaceuticals announced efforts to discover treatment for novel Coronavirus disease
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
Pluristem and Charit’ University of Medicine Berlin joinly target potential treatment for respiratory and inflammatory Intratissue complications caused by COVID-19
On Mar. 12, 2020, Pluristem Therapeutics announced it a collaborative agreement with the BIH Center for Regenerative Therapy…
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
Biotechnology | COVID-19 | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics
Emory University among U.S. sites to host clinical trial for COVID-19 treatment
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
U.S. Regional Biocontainment Lab to begin testing of Brilacidin against Coronavirus (COVID-19)
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
MediciNova announced plans to develop MN-166 (ibudilast) for severe pneumonia and ARDS
On Mar. 9, 2020, MediciNova announced that it planned to initiate development of MN-166 (ibudilast) for severe pneumonia…
Humanigen’s lenzilumab a potential therapeutic for lung damage arising from Coronavirus
On Mar. 9, 2020, Humanigen announced that it was actively exploring clinical stage strategies and partnerships to evaluate…
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
The FDA approved new treatment for adults with Cushing’s disease
On Mar. 6, 2020, the FDA approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either…
Government of Canada invested $27 million in Coronavirus research
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…
University of British Columbia researchers received $2.8 million in federal funding to help with global COVID-19 response
On Mar. 6, 2020, University of British Columbia (UBC) researchers Yue Qian, Dr. Richard Lester, Dr. Srinivas Murthy,…
Mount Sinai and Harbour BioMed collaborated to advance treatment of cancer and Coronavirus COVID-19
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
$100 million investment helped hospitals across Alberta upgrade operating rooms
On Mar. 5, 2020, a $100 million government investment was announced that helped hospitals across the province upgrade…
Scientists monitored brains replaying memories in real time
On Mar. 5, 2020, in a study of epilepsy patients, researchers at the National Institutes of Health (NIH)…
Heat Biologics collaborated with University of Miami to develop COVID-19 Coronavirus vaccine
On Mar. 5, 2020, Heat Biologics announced a strategic collaboration with the University of Miami Miller School of…
Cocrystal Pharma announced plans to advance Coronavirus program
On Mar. 6, 2020, Cocrystal Pharma announced it had initiated its Coronavirus program. Cocrystal previously entered into a…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
Oregon Health Sciences doctors first to use CRISPR editing for inherited form of blindness
On Mar. 4, 2020, doctors at the Casey Eye Institute at Oregon Health & Science University in Portland…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
Mateon updated Rapid Antiviral Response Program Initially targeting COVID-19
On Mar. 2, 2020, Mateon Therapeutics reported the company had been evaluating its therapeutic and AI platforms to…